CRL Annual Current Liabilities
$1.06 B
-$36.50 M-3.34%
30 December 2023
Summary:
As of January 21, 2025, CRL annual total current liabilities is $1.06 billion, with the most recent change of -$36.50 million (-3.34%) on December 30, 2023. During the last 3 years, it has risen by +$215.33 million (+25.64%). CRL annual current liabilities is now -3.34% below its all-time high of $1.09 billion, reached on December 31, 2022.CRL Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly Current Liabilities
$1.01 B
+$64.70 M+6.83%
28 September 2024
Summary:
As of January 21, 2025, CRL quarterly total current liabilities is $1.01 billion, with the most recent change of +$64.70 million (+6.83%) on September 28, 2024. Over the past year, it has dropped by -$42.86 million (-4.06%). CRL quarterly current liabilities is now -7.27% below its all-time high of $1.09 billion, reached on December 31, 2022.CRL Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.3% | -4.1% |
| 3 y3 years | +25.6% | -4.1% |
| 5 y5 years | +89.0% | -4.1% |
CRL Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.3% | +2.1% | -7.3% | +6.8% |
| 5 y | 5-year | -3.3% | +48.6% | -7.3% | +46.5% |
| alltime | all time | -3.3% | +1617.8% | -7.3% | +1571.7% |
Charles River Laboratories International Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.01 B(+6.8%) |
| June 2024 | - | $947.52 M(-0.8%) |
| Mar 2024 | - | $954.81 M(-9.5%) |
| Dec 2023 | $1.06 B(-3.3%) | $1.06 B(+6.2%) |
| Sept 2023 | - | $993.82 M(-1.4%) |
| June 2023 | - | $1.01 B(+2.7%) |
| Mar 2023 | - | $981.39 M(-10.1%) |
| Dec 2022 | $1.09 B(+5.7%) | $1.09 B(+7.6%) |
| Sept 2022 | - | $1.01 B(-3.2%) |
| June 2022 | - | $1.05 B(+5.5%) |
| Mar 2022 | - | $993.84 M(-3.8%) |
| Dec 2021 | $1.03 B(+23.0%) | $1.03 B(+5.0%) |
| Sept 2021 | - | $983.75 M(+5.8%) |
| June 2021 | - | $929.61 M(+15.7%) |
| Mar 2021 | - | $803.38 M(-4.3%) |
| Dec 2020 | $839.75 M(+18.2%) | $839.75 M(+6.7%) |
| Sept 2020 | - | $787.01 M(+8.1%) |
| June 2020 | - | $727.94 M(+5.4%) |
| Mar 2020 | - | $690.90 M(-2.7%) |
| Dec 2019 | $710.18 M(+27.2%) | $710.18 M(+4.2%) |
| Sept 2019 | - | $681.65 M(+7.2%) |
| June 2019 | - | $635.60 M(+20.0%) |
| Mar 2019 | - | $529.76 M(-5.1%) |
| Dec 2018 | $558.22 M(+20.4%) | $558.22 M(+3.5%) |
| Sept 2018 | - | $539.60 M(+4.1%) |
| June 2018 | - | $518.14 M(+27.3%) |
| Mar 2018 | - | $407.10 M(-12.2%) |
| Dec 2017 | $463.50 M(+7.9%) | $463.50 M(+11.5%) |
| Sept 2017 | - | $415.75 M(-2.0%) |
| June 2017 | - | $424.07 M(+10.6%) |
| Mar 2017 | - | $383.37 M(-10.8%) |
| Dec 2016 | $429.59 M(+37.8%) | $429.59 M(+4.3%) |
| Sept 2016 | - | $412.05 M(-0.3%) |
| June 2016 | - | $413.39 M(+33.4%) |
| Mar 2016 | - | $309.99 M(-0.6%) |
| Dec 2015 | $311.76 M(+5.8%) | $311.76 M(-0.7%) |
| Sept 2015 | - | $314.10 M(+13.6%) |
| June 2015 | - | $276.53 M(+2.2%) |
| Mar 2015 | - | $270.49 M(-8.2%) |
| Dec 2014 | $294.69 M(+19.3%) | $294.69 M(+4.1%) |
| Sept 2014 | - | $283.08 M(+4.2%) |
| June 2014 | - | $271.65 M(+13.5%) |
| Mar 2014 | - | $239.32 M(-3.1%) |
| Dec 2013 | $247.03 M(-27.8%) | $247.03 M(+5.0%) |
| Sept 2013 | - | $235.17 M(+4.1%) |
| June 2013 | - | $225.85 M(-31.7%) |
| Mar 2013 | - | $330.81 M(-3.3%) |
| Dec 2012 | $342.25 M | $342.25 M(+5.2%) |
| Sept 2012 | - | $325.24 M(-0.9%) |
| June 2012 | - | $328.13 M(+46.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $223.84 M(+3.2%) |
| Dec 2011 | $216.80 M(-16.5%) | $216.80 M(-3.1%) |
| Sept 2011 | - | $223.84 M(-19.2%) |
| June 2011 | - | $277.10 M(-10.0%) |
| Mar 2011 | - | $307.81 M(+18.5%) |
| Dec 2010 | $259.78 M(+4.0%) | $259.78 M(+9.4%) |
| Sept 2010 | - | $237.38 M(-3.5%) |
| June 2010 | - | $246.06 M(-0.5%) |
| Mar 2010 | - | $247.22 M(-1.0%) |
| Dec 2009 | $249.77 M(-17.0%) | $249.77 M(-1.7%) |
| Sept 2009 | - | $254.10 M(-5.8%) |
| June 2009 | - | $269.64 M(-3.7%) |
| Mar 2009 | - | $279.87 M(-7.0%) |
| Dec 2008 | $301.00 M(-0.5%) | $301.00 M(-41.3%) |
| Sept 2008 | - | $512.51 M(+2.3%) |
| June 2008 | - | $500.77 M(+65.4%) |
| Mar 2008 | - | $302.84 M(+0.1%) |
| Dec 2007 | $302.53 M(+16.7%) | $302.53 M(+4.2%) |
| Sept 2007 | - | $290.37 M(+7.7%) |
| June 2007 | - | $269.68 M(+9.5%) |
| Mar 2007 | - | $246.29 M(-5.0%) |
| Dec 2006 | $259.33 M(-16.7%) | $259.33 M(+2.3%) |
| Sept 2006 | - | $253.58 M(-7.8%) |
| June 2006 | - | $275.12 M(+2.6%) |
| Mar 2006 | - | $268.02 M(-13.9%) |
| Dec 2005 | $311.41 M(-10.8%) | $311.41 M(-2.1%) |
| Sept 2005 | - | $318.25 M(+0.6%) |
| June 2005 | - | $316.22 M(-2.9%) |
| Mar 2005 | - | $325.76 M(-6.7%) |
| Dec 2004 | $349.12 M(+205.3%) | $349.12 M(+156.6%) |
| Sept 2004 | - | $136.07 M(+11.2%) |
| June 2004 | - | $122.36 M(+10.5%) |
| Mar 2004 | - | $110.71 M(-3.2%) |
| Dec 2003 | $114.35 M(+0.9%) | $114.35 M(+3.4%) |
| Sept 2003 | - | $110.56 M(+7.3%) |
| June 2003 | - | $103.07 M(-0.6%) |
| Mar 2003 | - | $103.66 M(-8.6%) |
| Dec 2002 | $113.37 M(+15.1%) | $113.37 M(+12.4%) |
| Sept 2002 | - | $100.90 M(-1.4%) |
| June 2002 | - | $102.38 M(+14.1%) |
| Mar 2002 | - | $89.69 M(-9.0%) |
| Dec 2001 | $98.53 M(+53.2%) | $98.53 M(+13.7%) |
| Sept 2001 | - | $86.63 M(+7.7%) |
| June 2001 | - | $80.46 M(-19.0%) |
| Mar 2001 | - | $99.30 M(+54.4%) |
| Dec 2000 | $64.32 M(+4.7%) | $64.32 M(+6.2%) |
| Sept 2000 | - | $60.55 M(-9.7%) |
| June 2000 | - | $67.08 M(-20.1%) |
| Mar 2000 | - | $83.92 M |
| Dec 1999 | $61.42 M(-1.5%) | - |
| Dec 1998 | $62.39 M | - |
FAQ
- What is Charles River Laboratories International annual total current liabilities?
- What is the all time high annual current liabilities for Charles River Laboratories International?
- What is Charles River Laboratories International annual current liabilities year-on-year change?
- What is Charles River Laboratories International quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly current liabilities year-on-year change?
What is Charles River Laboratories International annual total current liabilities?
The current annual current liabilities of CRL is $1.06 B
What is the all time high annual current liabilities for Charles River Laboratories International?
Charles River Laboratories International all-time high annual total current liabilities is $1.09 B
What is Charles River Laboratories International annual current liabilities year-on-year change?
Over the past year, CRL annual total current liabilities has changed by -$36.50 M (-3.34%)
What is Charles River Laboratories International quarterly total current liabilities?
The current quarterly current liabilities of CRL is $1.01 B
What is the all time high quarterly current liabilities for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly total current liabilities is $1.09 B
What is Charles River Laboratories International quarterly current liabilities year-on-year change?
Over the past year, CRL quarterly total current liabilities has changed by -$42.86 M (-4.06%)